CLINICAL_TRIALS trial_result · 2024-11-05

Clinical Trial Update: A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction [Phase 1]

A Phase 1 trial of PF-07081532 in people with type 2 diabetes mellitus and chronic kidney disease was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Type 2 Diabetes, Renal Impairment | Phase 1 | Status: TERMINATED | Results posted: 2024-11-05